Organization · Venture Capital
Medical Technology Venture Partners
Medical Technology Venture Partners is an early-stage investment firm specializing in medical devices and diagnostics. They provide funding and operational expertise to entrepreneurs in the healthcare technology sector.
Overview
What Medical Technology Venture Partners does
What Medical Technology Venture Partners is
Medical Technology Venture Partners is an early-stage investment firm specializing in medical devices and diagnostics. They provide funding and operational expertise to entrepreneurs in the healthcare technology sector.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 23, 2026
Official channels
Find Medical Technology Venture Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Medical Technology Venture Partners as a funder
Investment thesis
MedTech Venture Partners is an early-stage investment firm specializing in medical devices and diagnostics. The team's differentiated value-add is hands-on operational expertise, emphasizing deep clinical and regulatory knowledge to support portfolio companies.
Focus narrative
MedTech Venture Partners invests in novel therapeutic and diagnostic medical devices across the regulatory spectrum. They typically target seed or Series A rounds, focusing on companies with advanced prototypes and strong bench and animal data. While they are open to various stages of investment, their primary focus remains on early-stage companies.
Value beyond capital
MedTech Venture Partners adds value to its portfolio companies through hands-on operational expertise and deep clinical and regulatory knowledge. Their extensive experience in launching medical devices and diagnostics products allows them to provide critical support beyond capital.
Terms and economics
- Typical check
- $500,000–$3,000,000
Focus and fit
- Stages
- Seed · Series A · Friends and Family · Accelerator
- Sectors
- Healthcare · Medical Devices · Diagnostics
- Regions
- North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 10
- Recorded notable exits
- Novonate, Reglind, and Siris Medical
Portfolio context
Notable portfolio companies include Cala Health, which develops wearable neuromodulation devices for chronic diseases; Centese, offering an intelligent surgical drainage system; GT Medical Technologies, focusing on targeted radiation therapy; and Novonate, which provides a neonate umbilical catheter protection device. Other companies include Reglind, Siris Medical, Suono Bio, Thrombx Medical, Verana Health, and Zenflow.
Common questions
What to know about Medical Technology Venture Partners
Upseed classifies Medical Technology Venture Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 23, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.